Andreas Turzynski
Impact in
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Melanoma and MAPK Pathways 2
- PI3K/AKT/mTOR signaling in cancer 2
- Glycosylation and Glycoproteins Research 1
- Oncology 7
- HER2/EGFR in Cancer Research 3
- Bone health and treatments 2
- Co-authors
- H. W. Schütz (2 shared papers)S. Ritz (2 shared papers)Rolf Mentlein (2 shared papers)Axel Hollmann (1 shared paper)Manfred Dietel (3 shared papers)Kai Wiechen (2 shared papers)Steffen Hauptmann (1 shared paper)Antje Siegert (1 shared paper)
- Journals
- Forensic Science International (2 papers)Journal of Clinical Oncology (1 paper)Brain Research (1 paper)Clinical & Experimental Metastasis (1 paper)Recent results in cancer research (1 paper)
- Partner nations
- GermanyUnited StatesIran
In The Last Decade
Andreas Turzynski
15 papers receiving 383 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 63
- Oncology 113
- Archeology 46
- Molecular Biology 171
- Biochemistry 17
Countries citing papers authored by Andreas Turzynski
This map shows the geographic impact of Andreas Turzynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Turzynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Turzynski more than expected).
Fields of papers citing papers by Andreas Turzynski
This network shows the impact of papers produced by Andreas Turzynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Turzynski. The network helps show where Andreas Turzynski may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Turzynski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 66 | |
| 2 | 2010 | 50 | |
| 3 | 2002 | 44 | |
| 4 | 1990 | 41 | |
| 5 | 1994 | 39 | |
| 6 | 1998 | 32 | |
| 7 | 2008 | 30 | |
| 8 | 2022 | 29 | |
| 9 | 1995 | 23 | |
| 10 | 1993 | 10 | |
| 11 | 1999 | 10 | |
| 12 | 1999 | 9 | |
| 13 | 2007 | 5 | |
| 14 | 1994 | 2 | |
| 15 | 2013 | 1 | |
| 16 | 2022 | 1 |
About Andreas Turzynski
Andreas Turzynski is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience, having authored 16 papers that have together received 392 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Melanoma and MAPK Pathways (2 papers), Bone health and treatments (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper). The work is most often cited by research in Cancer Research (63 citations), Oncology (113 citations), Archeology (46 citations), Molecular Biology (171 citations) and Biochemistry (17 citations). Andreas Turzynski has collaborated with scholars based in Germany, United States and Iran. Frequent co-authors include H. W. Schütz, S. Ritz, Rolf Mentlein, Axel Hollmann, Manfred Dietel, Kai Wiechen, Steffen Hauptmann, Antje Siegert, Carsten Denkert and Markus Müller. Their work appears in journals such as Forensic Science International, Journal of Clinical Oncology, Brain Research, Clinical & Experimental Metastasis and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.